Anna Lisa Furfaro

6PUBLICATIONS
25CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersHaematological tumoursMechanobiologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 28, 2026
Heme Oxygenase-1 Contributes to Dampening Proinflammatory Activation in the Human Microglial Cell Line HMC3 and Controls the Transcription Factor IRF5.

|May 15, 2025
AhR, IRF5, and HO-1 Expression in Evaluating Carotid Atherosclerotic Plaque Vulnerability: A Pilot Observational Study.

Chiara Barisione, Silvia Ortona, Caterina Ivaldo

|Aug 26, 2022
Hormesis and Oxidative Distress: Pathophysiology of Reactive Oxygen Species and the Open Question of Antioxidant Modulation and Supplementation.

Mariapaola Nitti, Barbara Marengo, Anna Lisa Furfaro

|Jun 24, 2022
HO-1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAFV600E Mutated Melanoma Cells Adapted to Physiological Normoxia or Hypoxia.

Anna Lisa Furfaro, Giulia Loi, Caterina Ivaldo

|Jun 02, 2021
Clinical Significance of Heme Oxygenase 1 in Tumor Progression.

Mariapaola Nitti, Caterina Ivaldo, Nicola Traverso

|Jul 16, 2016
Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy.

Barbara Marengo, Mariapaola Nitti, Anna Lisa Furfaro

Pageof 1

Frequent Collaborators

3 joint publications

Mariapaola Nitti

2 joint publications

Barbara Marengo

2 joint publications

Cinzia Domenicotti

2 joint publications

Mario Passalacqua